Close Menu
    Latest Category
    • Finance
    • Tech
    • EU Law
    • Energy
    • About
    • Contact
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Login
    • EU News
    • Focus
    • Guides
    • Press
    • Jobs
    • Events
    • Directory
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Home » EU clears ‘safe and effective’ Moderna vaccine against COVID-19

    EU clears ‘safe and effective’ Moderna vaccine against COVID-19

    npsBy nps12 January 2021 No Comments2 Mins Read
    — Filed under: EU News Headline1 Health
    Share
    Facebook Twitter LinkedIn Pinterest Email
    EU clears 'safe and effective' Moderna vaccine against COVID-19

    Coronavirus vaccine – Photo © European Union

    (BRUSSELS) – The EU Commission granted conditional marketing authorisation for the COVID-19 vaccine developed by US firm Moderna Wednesday, making it the second COVID-19 vaccine authorised in the Union.

    This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and is endorsed by the Member States.

    “Today we are authorising a second safe and effective vaccine from Moderna, which together with BioNTech-Pfizer, will ensure that 460 million doses will be rolled out with increasing speed in the EU, and more will come,” said the Health Commissioner Stella Kyriakides.

    Moderna submitted on 30 November 2020 an application for marketing authorisation to EMA, which had already started a rolling review of the data in November. Thanks to this rolling review, EMA has been assessing the quality, safety and efficacy of the vaccine as data has become available. EMA’s human medicines committee (CHMP) has thoroughly assessed the data and recommended by consensus that a formal conditional marketing authorisation is granted. A conditional marketing authorisation is one of EU’s regulatory mechanisms for facilitating early access to medicines that fulfil an unmet medical need, including in emergency situations such as the current pandemic.

    On the basis of EMA’s positive opinion, the Commission has verified all the elements supporting the marketing authorisation and consulted Member States before granting the conditional market authorisation.

    The Moderna vaccine is based on messenger RNA (mRNA). mRNA plays a fundamental role in biology, transferring instructions from DNA to the cells’ protein making machinery. In an mRNA vaccine, these instructions produce harmless fragments of the virus, which the human body uses to build an immune response to prevent or fight disease.

    When a person is given the vaccine, their cells will read the genetic instructions and produce a spike protein, a protein on the outer surface of the virus which it uses to enter the body’s cells and cause disease. The person’s immune system will then treat this protein as foreign and produce natural defences — antibodies and T cells — against it.

    EU Vaccines Strategy

    Questions and Answers: Conditional marketing authorisation of COVID-19 vaccines

    Add A Comment
    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    nps
    • Website

    Related Content

    Sustainable finance - Image by Nattanan Kanchanaprat from Pixabay

    Brussels eases corporate sustainability reporting requirements

    Tochytskyi - Micallef - Ukraine Recovery Conference - Photo © European Union 2025

    EU offers support for Ukraine culture and heritage

    Euro - ECB-Photo by Mika Baumeister on Unsplash

    Poor GDP performance marks end of tough week for the Pound – Euro currency news daily

    Ukraine Recovery Conference - Photo © European Union 2025

    EU announces EUR 2.3 billion package for Ukraine recovery

    Ecommerce - Photo by AS Photography on Pexels

    Euro-Parliament moves to stop sub-standard products from outside EU

    Deforestation - Image by Robert Jones from Pixabay

    EUDR saga: Parliament votes to undermine enforcement and EU credibility

    Sponsor: WWF European Policy Office9 July 2025
    LATEST EU NEWS
    Sustainable finance - Image by Nattanan Kanchanaprat from Pixabay

    Brussels eases corporate sustainability reporting requirements

    11 July 2025
    Tochytskyi - Micallef - Ukraine Recovery Conference - Photo © European Union 2025

    EU offers support for Ukraine culture and heritage

    11 July 2025
    Euro - ECB-Photo by Mika Baumeister on Unsplash

    Poor GDP performance marks end of tough week for the Pound – Euro currency news daily

    11 July 2025
    Ukraine Recovery Conference - Photo © European Union 2025

    EU announces EUR 2.3 billion package for Ukraine recovery

    10 July 2025
    Ecommerce - Photo by AS Photography on Pexels

    Euro-Parliament moves to stop sub-standard products from outside EU

    10 July 2025

    Subscribe to EUbusiness Week

    Get the latest EU news

    CONTACT INFO

    • EUbusiness Ltd 117 High Street, Chesham Buckinghamshire, HP5 1DE United Kingdom
    • +44(0)20 8058 8232
    • service@eubusiness.com

    INFORMATION

    • About Us
    • Advertising
    • Contact Info

    Services

    • Privacy Policy
    • Terms
    • EU News

    SOCIAL MEDIA

    Facebook
    eubusiness.com © EUbusiness Ltd 2025

    Design and developed by : 

    Type above and press Enter to search. Press Esc to cancel.

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?